Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
United Therapeutics Reports First Pig Kidney Transplant in Trial

United Therapeutics Reports First Pig Kidney Transplant in Trial

MT newswireMT newswire2026/11/20 11:44
07:44 AM EST, 11/20/2026 (MT Newswires) -- United Therapeutics (UTHR) said Friday the first patient received its investigational UThymoKidney, a genetically modified pig kidney, in a trial for patients with end-stage renal disease. The transplant was performed at NYU Langone Health, and the trial will test safety and effectiveness in patients who are ineligible for a conventional human kidney transplant or unlikely to receive one within five years, the company said. The pig kidney contains thymus tissue meant to help the immune system accept the organ and has a gene edit to remove a sugar on cell surfaces that triggers rejection, United Therapeutics said.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

OpenAI Chief Scientist Proposes Setting an "Industry Cap" for AI Development Before Comprehension Capabilities Catch Up

OpenAI Chief Scientist Jakub Pachocki suggested that artificial intelligence companies should reach a consensus to impose limits on the development of increasingly powerful models until researchers find better ways to understand and monitor model behavior.

智通财经•2026/11/22 23:31
OpenAI Chief Scientist Proposes Setting an "Industry Cap" for AI Development Before Comprehension Capabilities Catch Up